Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Nov 09 2020

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-09-2020-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases